User profiles for Kenneth J. Warrington

Kenneth Warrington

Professor of Medicine, Mayo Clinic College of Medicine and Science
Verified email at mayo.edu
Cited by 13084

The lifetime risk of adult‐onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases

…, CJ Michet, FC Ernste, KJ Warrington… - Arthritis & …, 2011 - Wiley Online Library
Objective Understanding of the personal risks for rheumatoid arthritis (RA) and other rheumatic
diseases remains poor, despite advances in knowledge with regard to their pathogenesis…

T-cell–mediated lysis of endothelial cells in acute coronary syndromes

T Nakajima, S Schulte, KJ Warrington, SL Kopecky… - Circulation, 2002 - Am Heart Assoc
Background— CD4 T lymphocytes accumulate in unstable plaque. The direct and indirect
involvement of these T cells in tissue injury and plaque instability is not understood. Methods …

Sarilumab for relapse of polymyalgia rheumatica during glucocorticoid taper

…, S Unizony, KJ Warrington, J Sloane… - … England Journal of …, 2023 - Mass Medical Soc
Background More than half of patients with polymyalgia rheumatica have a relapse during
tapering of glucocorticoid therapy. Previous studies have suggested that interleukin-6 …

Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis

…, GG Hunder, EL Matteson, KJ Warrington - Seminars in arthritis and …, 2012 - Elsevier
OBJECTIVES: To evaluate the utility of erythrocyte sedimentation rate (ESR) and C-reactive
protein (CRP) for the diagnosis of giant cell arteritis (GCA) and to determine the frequency of …

Large-vessel giant cell arteritis: a cohort study

…, C Salvarani, EL Matteson, KJ Warrington - …, 2015 - academic.oup.com
Objective. The aim of this study was to compare baseline variables, treatment and outcomes
in patients with large-vessel GCA (LV-GCA), primarily of the upper extremities, with those …

Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis

TA Kermani, KJ Warrington, CS Crowson… - Annals of the …, 2013 - ard.bmj.com
Objectives To evaluate incidence-trends and timing of large-vessel (LV) manifestations in
patients with giant cell arteritis (GCA), and to examine the influence of LV manifestations on …

A randomized, double‐blind trial of abatacept (CTLA‐4Ig) for the treatment of giant cell arteritis

…, R Spiera, CA McAlear, KJ Warrington… - Arthritis & …, 2017 - Wiley Online Library
Objective To compare the efficacy of abatacept to that of placebo for the treatment of giant cell
arteritis (GCA). Methods In this multicenter trial, patients with newly diagnosed or relapsing …

Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study

…, JM Davis, TG Mason, KJ Warrington… - Annals of the …, 2015 - ard.bmj.com
Objectives To assess the accuracy of dual-energy CT (DECT) for diagnosing gout, and to
explore whether it can have any impact on clinical decision making beyond the established …

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

…, G Le Guenno, A Bigot, KJ Warrington… - Blood, The Journal …, 2022 - ashpublications.org
VEXAS syndrome (vacuoles in myeloid progenitors, E1 ubiquitin activating enzyme, X-linked,
autoinflammatory manifestations and somatic) is an autoinflammatory condition caused by …

Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis

…, PA Monach, P Seo, KJ Warrington… - Annals of the …, 2012 - ard.bmj.com
Objectives To compare patterns of arteriographic lesions of the aorta and primary branches
in patients with Takayasu's arteritis (TAK) and giant cell arteritis (GCA). Methods Patients …